Nutra Pharma Corp.
News and overview for Nutra Pharma Corp.
Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process
News-Medical.Net | 9 days 21 hours 49 minutes ago
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.
Cohen Independent Research Group publishes a report profiling Nutra Pharma
News-Medical.Net | 30 days 2 hours 11 minutes ago
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that Cohen Independent Research Group has published a report profiling Nutra Pharma Corporation
Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution [Press Release]
Business Wire | 3 days 17 hours 14 minutes ago
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today the introduction of Nyloxin OTC for the treatment of chronic pain. Nyloxin OTC will be marketed and sold internationally alongside the Company’s prescription pain reliever, Nyloxin Rx.
Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain [Press Release]
Business Wire | 39 days 18 hours 17 minutes ago
Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its over-the-counter pain reliever, Cobroxin, is available for sale online at Cobroxin.com.
Nutra Pharma Announces Publication of Research Report by Cohen Independent Research Group [Press Release]
Business Wire | 31 days 12 hours 29 minutes ago
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that Cohen Independent Research Group has published a report profiling Nutra Pharma Corporation. The report, which was commissioned by Nutra Pharma, focuses on the company’s current drug development initiatives, including the company’s leading drug candidates for the treatment of Multiple Sclerosis (MS), HIV, Adrenomyelon...
Nutra Pharma launches drug with cobra venom
American City Business Journals | 39 days 14 hours 58 minutes ago
Plantation-based Nutra Pharma Corp. has launched sales of an over-the-counter pain reliever that uses Asian cobra venom as the active ingredient.
Cobroxin OTC pain reliever is now available online
News-Medical.Net | 38 days 22 hours 59 minutes ago
Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its over-the-counter pain reliever, Cobroxin, is available for sale online at Cobroxin.com.
7 Results
Sign up for FDLI SmartBrief
Company Overview
| Company: | Nutra Pharma Corp. |
|---|---|
| Industry: | Biopharmaceuticals & Biotherapeutics |
| Website: | http://www.nutrapharma.com |
Nutra Pharma is a biotechnology holding company active in several areas. The company's ReceptoPharm subsidiary holds a pipeline of drug candidates that may eventually treat HIV/AIDS, rabies, and other viral and neurological diseases as well as pain. Another subsidiary, NanoLogix develops diagnostic test kits to identify infectious diseases, while its Designer Diagnostics subsidiary markets and sells the test kits. One product in development as a possible therapy for MS was based upon cobra venom. That product was then reformulated and launched commercially as a over-the-counter topical analgesic for chronic pain, under the brand name Cobroxin.
Key Numbers
| Sales in U.S. Dollars (mil.) | 0 (2008) |
|---|---|
| One-year % Growth in Sales | 0.0 (2008) |
| Net Income in U.S. Dollars (mil.) | -4.2 (2008) |
| One-year % Growth in Net Income | 0.0 (2008) |
| Number of Employees | 5 (2008) |
| One-year % Growth in Number of Employees | 66.7 (2008) |
| Fiscal Year-End | December |